Claims
- 1. A compound which is a member selected from the group consisting of
- N-�4-0-(2,3-epoxypropoxy)-3-methoxybenzyl!-nonamide,NVAE).
- N-�4-(2-hydroxy-3-(isopropylamino)propoxy)-3-methoxybenzyl!-nonamide,NVAEN)
- N-�4-(2-hydroxy-3-(n-propylamino)propoxy)-3-methoxybenzyl!-nonamide
- N-�4-)-(2-hydroxy-3-(methylamino)propoxy)-3-methoxybenzyl!-nonamide
- N-�4-(2-hydroxy-3(ethylamino)propoxy)-3-methoxybenzyl!-nonamide
- N-�4-0-(2-hydroxy-3-(allylamino)propoxy)-3-methoxybenzyl!-nonamide
- N-�4-(2-hydroxy-3-(cyclopropylamino)propoxy)-3-methoxybenzyl!-nonamide
- N-�4-(2-hydroxy-3-((n-butylamino)propoxy)-3-methoxybenzyl!-nonamide
- N-�4-(2-hydroxy-3-(iso-butylamino)propoxy)-3-methoxybenzyl!-nonamide
- N-�4-(2-hydroxy-3-(sec-butylamino)propoxy)-3-methoxybenzyl!-nonamide
- N-�4-(2-hydroxy-3-(tert-butylamino)propoxy)-3-methoxybenzyl!-nonamide
- N-�4-(2-hydroxy-3-(n-pentylamino)propoxy)-3-methoxybenzyl!-nonamide
- N-�4-(2-hydroxy-3-(3-aminopentylamino)propoxy)-3-methoxybenzyl!-nonamide
- N-�4-(2-hydroxy-3-(n-hexylamino)propoxy)-3-methoxybenzyl!-nonamide
- N-�4-(2-hydroxy-3-(cyclohexylamino)propoxy)-3-methoxybenzyl!-nonamide
- N-�4-(2-hydroxy-3-(n-heptylamino)propoxy)-3-methoxybenzyl!-nonamide
- N-�4-(2-hydroxy-3-(benzylamino)propoxy)-3-methoxybenzyl!nonamide
- N-(4-0-dimethylaminoethyl-3-methoxybenzyl)-nonamide
- N-(4-0-diethylaminoethyl-3-methoxybenzyl)-nonamide
- N-(4-0-pyridylmethyl-3-methoxybenzyl)-nonamide and
- N-(4-0-piperidylethyl-3-methoxybenzyl)-nonamide.
- 2. A method of treatment of a living subject in need of a B-adrenergic blocker to reduce the blood pressure which consists of administering to said subject a composition containing an effective amount of a compound which is a member selected from the group consisting of
- N-�4-0-(2,3-epoxypropoxy)-3-methoxybenzyl!-nonamide,NVAE)
- N-�4-(2-hydroxy-3-(isopropylamino)propoxy)-3-methoxybenzyl!-nonamide,NVAEN)
- N-�4-(2-hydroxy-3-(n-propylamino)propoxy)-3-methoxybenzyl!-nonamide
- N-�4)-(2-hydroxy-3-(methylamino)propoxy)-3-methoxybenzyl!-nonamide
- N-�4-(2-hydroxy-3(ethylamino)propoxy)-3-methoxybenzyl!-nonamide
- N-�4-0-(2-hydroxy-3-(allylamino)propoxy)-3-methoxybenzyl!-nonamide
- N-�4-(2-hydroxy-3-(cyclopropylamino)propoxy)-3-methoxybenzyl!-nonamide
- N-�4-(2-hydroxy-3-((n-butylamino)propoxy)-3-methoxybenzyl!-nonamide
- N-�4-(2-hydroxy-3-(iso-butylamino)propoxy)-3-methoxybenzyl!-nonamide
- N-�4-(2-hydroxy-3-(sec-butylamino)propoxy)-3-methoxybenzyl!-nonamide
- N-�4-(2-hydroxy-3-(tert-butylamino)propoxy)-3-methoxybenzyl!-nonamide
- N-�4-(2-hydroxy-3-(n-pentylamino)propoxy)-3-methoxybenzyl!-nonamide
- N-�4-(2-hydroxy-3-(3-aminopentylamino)propoxy)-3-methoxybenzyl!-nonamide
- N-�4-(2-hydroxy-3-(n-hexylamino)propoxy)-3-methoxybenzyl!-nonamide
- N-�4-(2-hydroxy-3-(cyclohexylamino)propoxy)-3-methoxybenzyl!-nonamide
- N-�4-(2-hydroxy-3-(n-heptylamino)propoxy)-3-methoxybenzyl!-nonamide
- N-�4-(2-hydroxy-3-(benzylamino)propoxy)-3-methoxybenzyl!nonamide
- N-(4-0-dimethylaminoethyl-3-methoxybenzyl)-nonamide
- N-(4-0-diethylaminoethyl-3-methoxybenzyl)-nonamide
- N-(4-0-pyridylmethyl-3-methoxybenzyl)-nonamide and
- N-(4-0-piperidylethyl-3-methoxybenzyl)-nonamide.
- 3. A .beta. adrenegic blocker composition in unit dosage form containing a compound according to claim 1 in the amount of 60 mgs per dose and a therapeutically inert carrier.
Parent Case Info
This application is a Continuation-In-Part of U.S. Ser. No. 08/157,473 filed Nov. 26, 1993, abandoned.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
3663607 |
Barrett et al. |
May 1972 |
|
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
157473 |
Nov 1993 |
|